1. The past time-series ILI occurrences over the 5 weeks exhibited a clear downward trend, with values of ['1271', '1454', '1284', '1170', '1117'] between Week 53, 2020, and Week 4, 2021. This decline was marked by an initial peak of 1454 in Week 1, 2021, followed by a steady decrease to 1117 in Week 4, 2021. This downward trajectory suggests a reduction in ILI activity during this period, likely influenced by various factors highlighted in the CDC reports.

2. A negative correlation between past and future ILI occurrences is evident, as the decline observed in the past ILI data (Weeks 53, 2020, to 4, 2021) contrasts with the reported drop to 975 future occurrences after 5 weeks (Week 9, 2021). This aligns with the notion that the ongoing decreasing trend in past data extends to the future period as well, reflecting a continuation of reduced ILI activity.

3. Several key factors from the summarized CDC reports align with the decline to 975 future occurrences:
   - **Low influenza positivity rates**: Influenza positivity remained exceptionally low across all weeks (as low as 0.1%-0.4%), substantially limiting the primary drivers of traditional ILI cases. This aligns with the ongoing decline observed in ILI cases.
   - **Minimal influenza-associated hospitalizations**: Hospitalization rates throughout Weeks 53, 2020, to Week 4, 2021, were significantly lower than average for this point in the season, with cumulative rates remaining stagnant at 0.5 per 100,000 population. This reflects the limited severity of ILI cases.
   - **Ongoing impacts of the COVID-19 pandemic**: Pandemic conditions, altered healthcare-seeking behaviors, and shifts in outpatient visits for respiratory illnesses likely supressed traditional ILI surveillance. CDC noted these disruptions consistently across all weeks, contributing to lower reported ILI occurrences by Week 9, 2021.

4. In summary, the decline in ILI occurrences to 975 by Week 9, 2021, is largely explained by the downward trend observed from Week 53, 2020, to Week 4, 2021, coupled with minimal influenza positivity rates, historically low influenza-associated hospitalizations, and persisting impacts of the COVID-19 pandemic on ILI surveillance.